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BACKGROUND: This project by the ICVR (International Consortium of 
Vascular Registries), a collaboration of 11 vascular surgical quality registries, 
was designed to evaluate international variation in the contemporary 
management of abdominal aortic aneurysm (AAA) with relation to 
recommended treatment guidelines from the Society for Vascular Surgery 
and the European Society for Vascular Surgery.
METHODS: Registry data for open and endovascular AAA repair (EVAR) 
during 2010 to 2013 were collected from 11 countries. Variations in patient 
selection and treatment were compared across countries and across centers 
within countries.
RESULTS: Among 51 153 patients, 86% were treated for intact AAA (iAAA) 
and 14% for ruptured AAA. Women constituted 18% of the entire cohort 
(range, 12% in Switzerland–21% in the United States; P<0.01). Intact AAAs 
were repaired at diameters smaller than recommended by guidelines in 31% 
of men (<5.5 cm; range, 6% in Iceland–41% in Germany; P<0.01) and 12% 
of women with iAAA (<5 cm; range, 0% in Iceland–16% in the United States; 
P<0.01). Overall, use of EVAR for iAAA varied from 28% in Hungary to 79% in 
the United States (P<0.01) and for ruptured AAA from 5% in Denmark to 52% 
in the United States (P<0.01). In addition to the between-country variations, 
significant variations were present between centers in each country in terms of 
EVAR use and rate of small AAA repair. Countries that more frequently treated 
small AAAs tended to use EVAR more frequently (trend: correlation coefficient, 
0.51; P=0.14). Octogenarians made up 23% of all patients, ranging from 12% 
in Hungary to 29% in Australia (P<0.01). In countries with a fee-for-service 
reimbursement system (Australia, Germany, Switzerland, and the United 
States), the proportions of small AAA (33%) and octogenarians undergoing 
iAAA repair (25%) were higher compared with countries with a population-based 
reimbursement model (small AAA repair, 16%; octogenarians, 18%; P<0.01). In 
general, center-level variation within countries in the management of AAA was 
as important as variation between countries.
CONCLUSIONS: Despite homogeneous guidelines from professional 
societies, significant variation exists in the management of AAA, most notably 
for iAAA diameter at repair, use of EVAR, and the treatment of elderly patients. 
ICVR provides an opportunity to study treatment variation across countries and 
to encourage optimal practice by sharing these results.
Variations in abdominal aortic aneurysm care
a report From the international consortium of Vascular registries
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abdominal aortic aneurysm (AAA) is a common dis-ease in the Western population, with a prevalence of 2% to 5% in men ≥65 years of age,1–3 and is a major 
cause of death as a result of rupture.4 Treatment consists 
of an open or endovascular aortic repair (EVAR).
Many aspects of treatment, including size threshold 
for intervention,5–8 the benefits of EVAR,9–12 and AAA 
screening in high-risk cohorts,1,13–15 have been studied 
extensively. Using the available data, both the Society 
for Vascular Surgery (SVS) and the European Society for 
Vascular Surgery (ESVS) have established guidelines for 
the management of AAA.16,17 The aim of these guidelines 
is to settle uncertainties in management and to identify 
best practices. However, treatment choices may be 
driven not only by clinical and medical science but also 
by cultural differences, economic incentives, access to 
technology, physician skill set, and patient/physician 
preference.18 Historically, significant variation in the man-
agement of AAA has been noted between some coun-
tries, but wider international variation related to society 
guidelines has not been assessed.19–22
Here, we assessed differences in contemporary prac-
tice for 11 countries across 3 continents participating 
in the ICVR (International Consortium of Vascular Reg-
istries),23 which is a collaboration of national quality im-
provement registries.
MethOds
Unidentifiable data from registries in 11 countries were sub-
mitted to the Medical Device Epidemiology Network Analytic 
Center at Weil Cornell University for analysis. The Table dem-
onstrates the countries involved and provides background data 
for each registry. Because of the nature of their registries, 
procedures performed during the studied time period were 
covered on the national level in Australia, Denmark, Hungary, 
Iceland, New Zealand, Norway, and Sweden. The Finnish regis-
try captured AAA repairs in 3 hospital regions (Helsinki, central 
Finland, and South Karelia), and the Swiss registry captured 
procedures performed within the Swiss public healthcare 
sector. Data from Germany included AAA repairs from ≈100 
centers participating in the German vascular registry. In the 
United States, 150 centers participating in the SVS Vascular 
Quality Initiative EVAR and open AAA registries were used in 
the analysis. These centers represent an estimated 15% of 
the aneurysm repairs performed in the United States over the 
time studied and essentially 100% of cases performed at each 
participating institution. Data for each Vascular Quality Initiative 
center are audited against claims data to ensure consecutive 
case entry.
All primary AAA repairs (intact [iAAA] and ruptured [rAAA]) 
collected between January 2010 and December 2013 were 
included (Figures I and II in the online-only Data Supplement). 
For Vascular Quality Initiative centers specifically, when the use 
of EVAR versus open AAA repair was examined, only centers 
participating in both the EVAR and open repair registries were 
included for that portion of the analysis (n=121). All analyses 
focusing on AAA size were limited to intact repairs for which 
AAA size was available. Cases with a registered AAA diameter 
of <4 cm were excluded because these procedures are likely 
to have been performed for indications other than degenera-
tive atherosclerotic aortic aneurysms (eg, iliac aneurysms, 
penetrating ulcer, dissection).
statistical analysis
The study was planned and performed in accordance with 
the STROBE (Strengthening the Reporting of Observational 
Studies in Epidemiology) guidelines for observational studies.24 
Demographics, comorbidities (diabetes mellitus, cardiac, pul-
monary, and renal and cerebrovascular disease), and opera-
tive data, including year of repair, indication (rupture/intact, 
AAA diameter), and technique (open/EVAR), were evaluated. 
The Norwegian registry provided age in 5-year groups rather 
than exact age, so estimates were derived from the median for 
each 5-year age group. Comorbidity definitions/severity var-
ied slightly across registries (Figure III in the online-only Data 
Supplement). Of note, both the SVS and the ESVS recommend 
a diameter threshold of ≥5.5 cm for elective repair in men, 
but they differ slightly in the recommendation for women (SVS, 
≥5.0 cm; ESVS, ≥5.2 cm). For the purposes of this analysis, 
small iAAA repair is defined as <5.5-cm diameter in men and 
<5-cm diameter in women.
Patient characteristics were presented as mean and SD for 
age and aneurysm diameter and as percentages for propor-
tions. One-way ANOVA and χ2 tests were used for assessment 
of inference for continuous variables (age and diameter) and 
proportions, respectively. Variations in patient characteristics 
and use of EVAR were assessed on both the country and center 
clinical Perspective
What is new?
•	This report by the International Consortium of Vas-
cular Registries is the first such study allowing an 
assessment of variations in repair of abdominal 
aortic aneurysms in 11 countries over 3 conti-
nents represented by 2 large societies with existing 
clinical guidelines for abdominal aortic aneurysm 
management.
•	The study demonstrates that significant variation 
exists between and within countries in the man-
agement of both elective and emergent abdominal 
aortic aneurysm repair with regard to surgical tech-
nique and management of elderly patients. These 
differences in management correlate with health-
care reimbursement models, which may explain 
some of the variation.
What are the clinical implications?
•	The report indicates that healthcare system and 
reimbursement have as much impact on treatment 
patterns and indication for surgery as scientific stud-
ies and guidelines, with both positive and negative 
incentives potentially affecting practice.
•	There is an opportunity for further international har-
monization of treatment algorithms for abdominal 
aortic aneurysm repair, especially considering the 
strength of existing guidelines for intact repair.
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levels. Proportions and their 95% Wald confidence intervals 
were obtained. Center-level data were available for a subset of 
the patients in the German registry and not at all for the vas-
cular registries in Norway and New Zealand. For center-level 
correlation assessment, procedures performed in Germany, 
Norway, and New Zealand were not included. To assess varia-
tions in practice on the basis of case volume, center volume 
variations were assessed by dividing centers in quartiles on the 
basis of averaged annual overall number of AAA repairs.
Covariations between various parameters (proportion of 
EVAR for iAAA, proportion of EVAR in rAAA, and proportion of 
small AAA repair) on both the country and center levels were 
assessed with the Pearson correlation test. Analysis of trend 
was performed within centers that enrolled in registries for all 4 
years. A Cochrane-Armitage test for trend was used to assess 
the trend of proportions of ruptured aneurysm repair and small 
aneurysm repair overall and within each country. Missing values 
were excluded from analysis. Countries were further evaluated 
on the basis of their healthcare economic model. To com-
pare differences in small aneurysm repair and octogenarians 
undergoing intact aneurysm repair between countries with dif-
ferent healthcare economic models, a generalized linear mixed 
model accounting for center and country clustering was used, 
adjusting for procedure year. To adjust for multiple compari-
sons, a value of P<0.01 was regarded as significant. All analy-
ses were performed with SAS version 9.3 (SAS Institute Inc, 
Cary, NC).
Ethics approval for the collection and analysis of vascular 
registry data was obtained on the basis of national regula-
tions for each registry for this international collaborative 
project.
results
A total of 51 153 patients were identified, 44 089 with 
iAAA (86%) and 7064 with rAAA (14%). Ruptured AAA 
rates (as a percentage of all treated AAA) ranged from 
8% in the United States to 29% in Finland (P<0.001). 
Overall, there was a trend toward lower rate of rAAA 
(Continued )
table.  national and Patient characteristics for aaa repair table.  continued
 Overall australia denmark Finland germany hungary iceland new Zealand norway sweden switzerland united states P Value
Registry and healthcare system
  Registry coverage*
 
National, 
62% capture
National, 
>95% capture
Helsinki region, 
>95% capture
130 centers National
National, 
>95% capture
National
National, 80% 
capture
National, >95% capture National, public care† 150 centers‡  
  National screening  No No No No No No No No Yes§ No Yes¶  
  Reimbursement system  FFS PB PB FFS PB PB PB PB PB FFS FFS  
  iAAA repairs within private health 
insurance, % of total iAAA repairs
 34 0 0 11 0 0 2.5 0 0 25 95  
Intact AAA repairs, n 44 089 6306 2239 461 12 572 849 76 1214 2095 3893 2174 12 210  
  Mean age‖ (SD), y 72.6 (8.5) 74.6 (7.9) 71.6 (6.9) 72.2 (9.2) 72.2 (8.6) 68.9 (8.6) 72.6 (7.1) 73.8 (8.2) 71.4 (8.0) 72.4 (7.3) 71.1 (9.0) 72.8 (8.9) <0.01
  Female sex, n (%) 5834 (17.4) 994 (15.8) 395 (17.6) 58 (12.6) 293 (14.1) 121 (14.3) 13 (17.1) 228 (18.8) 331 (15.8) 580 (14.9) 253 (11.8) 2568 (21.0) <0.01
  EVAR,# n (%) 28459 (65.1) 4646 (73.7) 759 (33.9) 213 (46.2) 8570 (68.2) 236 (27.8) 41 (53.9) 628 (51.7) 670 (32.0) 2213 (56.8) 1093 (50.3) 9390 (79.5) <0.01
  Mean diameter (SD), cm 6.0 (1.2) 5.9 (1.1) … 6.5 (1.2) 6.0 (1.4) 6.2 (1.3) 6.4 (1.2) 6.2 (1.1) 6.1 (1.1) 6.2 (1.2) 6.0 (1.2) 5.9 (1.1) <0.01
  Comorbidities, n (%)
   Diabetes mellitus 5283 (15.9) 931 (14.8) 248 (11.2) 88 (19.8) 398 (19.2) 142 (16.7) 10 (13.2) 150 (12.4) 233 (11.1) 476 (12.9) 284 (13.1) 2323 (19.1) <0.01
   Cardiac 20 485 (46.9) 3554 (56.4) 804 (36.4) 220 (49.3) 7519 (60.3) 439 (51.7) 32 (42.1) 584 (48.1) 939 (44.8) 1451 (39.7) 798 (36.7) 4145 (34.0) <0.01
   Pulmonary 11 208 (31.0) … 375 (17.0) 125 (28.3) 4950 (39.7) 222 (26.1) 27 (35.5) … 444 (21.2) 807 (22.2) 365 (16.8) 3893 (31.9) <0.01
   Cerebrovascular event 1333 (10.5) … 230 (10.4) 57 (12.9) 201 (9.7) … 13 (17.1) … 211 (10.1) 460 (12.7) 159 (7.3) 2 (11.8) <0.01
Ruptured AAA repairs, n 7064 1444 748 192 1444 187 21 220 334 1038 342 1094  
  Mean age‖ (SD), y 73.9 (9.1) 74.4 (9.3) 72.7 (7.7) 73.3 (9.5) 74.6 (9.8) 71.2 (9.7) 72.3 (8.0) 74.5 (8.7) 73.5 (8.7) 75.2 (7.8) 72.5 (9.6) 72.9 (9.6) <0.01
  Female sex, n (%) 1087 (18.6) 272 (18.8) 102 (13.6) 31 (16.1) 43 (19.9) 27 (14.4) 2 (9.5) 48 (21.8) 63 (18.9) 206 (19.8) 36 (10.7) 257 (23.5) <0.01
  EVAR,# n (%) 2108 (29.9) 574 (39.8) 38 (5.1) 19 (9.9) 450 (31.2) 14 (7.5) 4 (19.0) 24 (10.9) 39 (11.7) 304 (29.3) 85 (24.9) 557 (51.8) <0.01
  Comorbidities, n (%)
   Diabetes mellitus 719 (12.8) 172 (11.9) 86 (12.4) 29 (17.0) 35 (16.2) 29 (15.5) 2 (9.5) 19 (8.6) 29 (8.7) 119 (12.7) 30 (8.8) 169 (15.7) <0.01
   Cardiac 3063 (45.1) 692 (47.9) 234 (33.7) 78 (45.9) 973 (67.9) 118 (63.1) 12 (57.1) 93 (42.3) 144 (43.1) 330 (37.8) 92 (26.9) 297 (27.7) <0.01
   Pulmonary 1601 (31.3) … 113 (16.4) 40 (24.1) 731 (51.0) 61 (32.6) 6 (28.6) … 67 (20.1) 192 (22.1) 47 (13.7) 344 (32.1) <0.01
   Cerebrovascular event 314 (11.8) … 74 (10.7) 20 (11.9) 29 (13.4) … 1 (4.8) … 30 (9.0) 129 (14.6) 31 (9.1) 0 (0.0) <0.01
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table.  national and Patient characteristics for aaa repair table.  continued
 Overall australia denmark Finland germany hungary iceland new Zealand norway sweden switzerland united states P Value
Registry and healthcare system
  Registry coverage*
 
National, 
62% capture
National, 
>95% capture
Helsinki region, 
>95% capture
130 centers National
National, 
>95% capture
National
National, 80% 
capture
National, >95% capture National, public care† 150 centers‡  
  National screening  No No No No No No No No Yes§ No Yes¶  
  Reimbursement system  FFS PB PB FFS PB PB PB PB PB FFS FFS  
  iAAA repairs within private health 
insurance, % of total iAAA repairs
 34 0 0 11 0 0 2.5 0 0 25 95  
Intact AAA repairs, n 44 089 6306 2239 461 12 572 849 76 1214 2095 3893 2174 12 210  
  Mean age‖ (SD), y 72.6 (8.5) 74.6 (7.9) 71.6 (6.9) 72.2 (9.2) 72.2 (8.6) 68.9 (8.6) 72.6 (7.1) 73.8 (8.2) 71.4 (8.0) 72.4 (7.3) 71.1 (9.0) 72.8 (8.9) <0.01
  Female sex, n (%) 5834 (17.4) 994 (15.8) 395 (17.6) 58 (12.6) 293 (14.1) 121 (14.3) 13 (17.1) 228 (18.8) 331 (15.8) 580 (14.9) 253 (11.8) 2568 (21.0) <0.01
  EVAR,# n (%) 28459 (65.1) 4646 (73.7) 759 (33.9) 213 (46.2) 8570 (68.2) 236 (27.8) 41 (53.9) 628 (51.7) 670 (32.0) 2213 (56.8) 1093 (50.3) 9390 (79.5) <0.01
  Mean diameter (SD), cm 6.0 (1.2) 5.9 (1.1) … 6.5 (1.2) 6.0 (1.4) 6.2 (1.3) 6.4 (1.2) 6.2 (1.1) 6.1 (1.1) 6.2 (1.2) 6.0 (1.2) 5.9 (1.1) <0.01
  Comorbidities, n (%)
   Diabetes mellitus 5283 (15.9) 931 (14.8) 248 (11.2) 88 (19.8) 398 (19.2) 142 (16.7) 10 (13.2) 150 (12.4) 233 (11.1) 476 (12.9) 284 (13.1) 2323 (19.1) <0.01
   Cardiac 20 485 (46.9) 3554 (56.4) 804 (36.4) 220 (49.3) 7519 (60.3) 439 (51.7) 32 (42.1) 584 (48.1) 939 (44.8) 1451 (39.7) 798 (36.7) 4145 (34.0) <0.01
   Pulmonary 11 208 (31.0) … 375 (17.0) 125 (28.3) 4950 (39.7) 222 (26.1) 27 (35.5) … 444 (21.2) 807 (22.2) 365 (16.8) 3893 (31.9) <0.01
   Cerebrovascular event 1333 (10.5) … 230 (10.4) 57 (12.9) 201 (9.7) … 13 (17.1) … 211 (10.1) 460 (12.7) 159 (7.3) 2 (11.8) <0.01
Ruptured AAA repairs, n 7064 1444 748 192 1444 187 21 220 334 1038 342 1094  
  Mean age‖ (SD), y 73.9 (9.1) 74.4 (9.3) 72.7 (7.7) 73.3 (9.5) 74.6 (9.8) 71.2 (9.7) 72.3 (8.0) 74.5 (8.7) 73.5 (8.7) 75.2 (7.8) 72.5 (9.6) 72.9 (9.6) <0.01
  Female sex, n (%) 1087 (18.6) 272 (18.8) 102 (13.6) 31 (16.1) 43 (19.9) 27 (14.4) 2 (9.5) 48 (21.8) 63 (18.9) 206 (19.8) 36 (10.7) 257 (23.5) <0.01
  EVAR,# n (%) 2108 (29.9) 574 (39.8) 38 (5.1) 19 (9.9) 450 (31.2) 14 (7.5) 4 (19.0) 24 (10.9) 39 (11.7) 304 (29.3) 85 (24.9) 557 (51.8) <0.01
  Comorbidities, n (%)
   Diabetes mellitus 719 (12.8) 172 (11.9) 86 (12.4) 29 (17.0) 35 (16.2) 29 (15.5) 2 (9.5) 19 (8.6) 29 (8.7) 119 (12.7) 30 (8.8) 169 (15.7) <0.01
   Cardiac 3063 (45.1) 692 (47.9) 234 (33.7) 78 (45.9) 973 (67.9) 118 (63.1) 12 (57.1) 93 (42.3) 144 (43.1) 330 (37.8) 92 (26.9) 297 (27.7) <0.01
   Pulmonary 1601 (31.3) … 113 (16.4) 40 (24.1) 731 (51.0) 61 (32.6) 6 (28.6) … 67 (20.1) 192 (22.1) 47 (13.7) 344 (32.1) <0.01
   Cerebrovascular event 314 (11.8) … 74 (10.7) 20 (11.9) 29 (13.4) … 1 (4.8) … 30 (9.0) 129 (14.6) 31 (9.1) 0 (0.0) <0.01
AAA indicates abdominal aortic aneurysm; EVAR, endovascular aneurysm repair; FFS, fee for service; iAAA, intact abdominal aortic aneurysm; and PB, 
population based. Missing data: 0.1% of age, 23.0% of sex, 23.8% of diabetes mellitus, 1.3% of cardiac history, 19.3% of pulmonary history, and 69.9% 
of cerebrovascular event. 
*Coverage represents if the registry is on national level, regional level, or center level with voluntary participation of interested centers. The capture rate 
is presented for registries for which these data are available and represents a comparison of number of procedures registered in the registry compared 
with the procedures registered in the official health data set of the country.
†The Swiss vascular registry includes patients operated on for AAA in public hospitals and captures 85% of all open and 70% of all EVAR procedures 
in the country.
‡US data represent an estimated 15% of all aneurysm repairs performed in the country over the study period. All participating centers capture 100% of 
their consecutive cases, audited with billing data.
§All 65-year-old men are invited to ultrasound screening for AAA.
¶Medicare offers an initial screening ultrasound at 65 to 75 years of age for men who have smoked >100 cigarettes in their lifetime and to men and 
women with a family history of AAA.
‖Age in years was not provided by Norway data. Estimates were derived from the median for each 5-year age group: 30 years for <40-year group and 
95 years for the >90-year group.
#Percentage of EVAR procedure in the United States was obtained within the cohort that included only centers enrolling in both EVAR and open repair 
registries.
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repair over time (19.0% in 2010 to 17.6% in 2013; 
P=0.16).
There were important demographic differences for a 
number of variables (Table). Women represented 18% 
of all treated AAAs (range, 12% in Switzerland–21% in 
the United States; P<0.01). Mean age was 72.5 years 
for men and 74.7 years for women at treatment (range 
in men, 68.8 years in Hungary–74.1 years in Australia, 
P<0.01; range in women, 72.1 years in Hungary–76.6 
years in Australia, P<0.01). Octogenarians represented 
23% of all patients (men, 22% [range, 12% in Hunga-
ry–27% in Australia]; women, 30% [range, 15% in Hun-
gary–41% in Australia]; P<0.01). The lowest-volume cen-
ters (first quartile) performed <30 AAA repairs per year, 
whereas the highest-volume centers (fourth quartile) 
performed ≥95 repairs per year. The proportion of iAAA 
repairs performed at low-volume centers varied between 
countries from 20% in Sweden and the United States to 
46% in Australia (P<0.001).
aneurysm diameter at repair
Overall, 28% of iAAA repairs were for small AAAs (from 5% 
in Iceland–39% in Germany). The rate of small AAA was 
higher for those undergoing EVAR (31%) compared with 
open repair (21%; P<0.01). Most patients undergoing re-
pair for small AAA had a diameter close to (within 0.5 cm 
of) the recommended threshold (men, 73%; women, 74%). 
There was wide international variation in rate of small iAAA 
repair. On average, 31% of iAAA repairs were performed 
at a diameter <5.5 cm in men (range, 6% in Iceland–43% 
Germany; P<0.01) and 12% at <5-cm diameter in women 
(range, 0% in Iceland and Finland–16% in the United States 
and Germany; P<0.01; Figure 1A). As a result of the un-
certainties in the ESVS and SVS recommendation for iAAA 
repair threshold for women, a separate analysis was per-
formed to assess the proportion of women undergoing 
repair for iAAA <5.5 and <5.2 cm in each country (Fig-
ure IV in the online-only Data Supplement). This analysis 
confirmed all the previously mentioned variations between 
countries. In addition to the between-country variation in 
proportion of small AAAs repaired, there was significant 
variation between centers in each country in terms of the 
proportion of intact AAA repairs performed for small AAA 
(Figure 1B). Overall, in low-volume centers, small AAA con-
stituted 29% of the iAAA repairs compared with 28% in 
high-volume centers (P=0.08). An assessment of trends 
in the percentage of small iAAA repair over the study pe-
riod did not show a significant trend overall or in specific 
countries (data not shown).
Operative technique
Overall, EVAR was used in 65% of iAAA repairs and 30% 
of rAAA repairs. EVAR was used in 65% of iAAA repairs 
in men and less often in women (60%; P<0.01). There 
were marked differences in the use of EVAR for iAAA 
repair between the countries with the lowest (Hungary, 
28%) and highest (United States, 79%) use (P<0.01). 
Fewer than 40% of iAAA repairs in Hungary, Norway, and 
Denmark were performed as EVAR, whereas >60% of 
iAAA repairs in Germany, Australia, and the United States 
were EVAR. EVAR rates for iAAA in other countries varied 
between 40% and 60% (Figure 2A). There was a similar 
wide variation across countries in the use of EVAR for 
rAAA (Figure 2B). There was a correlation between EVAR 
use in the iAAA and rAAA setting on the national level 
(correlation coefficient, 0.92; P<0.01) and on the center 
level (correlation coefficient, 0.60; P<0.01). There was 
a trend toward a correlation between the proportion of 
patients treated for small AAA and the use of EVAR for 
iAAA repair on the country level (correlation coefficient, 
0.51; P=0.13) and center level (correlation coefficient, 
0.27; P<0.01; Figure 3). The results of the correlation 
analyses were consistent when performed across all 
years and when individual year data were analyzed. Anal-
ysis of operative technique at the center level showed a 
significant variation in use of EVAR in AAA repair between 
centers within each country, for example, from 0% to 
100% in Australia and 0% to 96% in Sweden (Figure 2C).
healthcare reimbursement Models
Australia, Germany, Switzerland, and the United States 
represent countries where the healthcare reimburse-
ment model is based, at least in part, on fee for service 
(Table). All other countries in the ICVR provide AAA treat-
ment primarily within a population-based reimbursement 
model. The proportion of small AAAs and the proportion 
of octogenarians undergoing iAAA repair were higher 
in fee-for-service countries compared with population-
based reimbursement countries (Figure 4). In a compari-
son using hierarchical analysis accounting for center- 
and country-level clustering and adjusting for procedure 
year, fee-for-service countries had significantly more 
small AAA repair (odds ratio, 2.25; 95% confidence in-
terval, 1.35–3.78; P<0.01) and slightly more octoge-
narians undergoing iAAA repair (odds ratio, 1.49; 95% 
confidence interval, 0.88–2.53; P=0.12) than countries 
with population-based reimbursement.
threshold diameter for elective repair Versus 
rupture rate
As noted, the proportion of repairs for rAAA varied sig-
nificantly between countries. Because more frequent re-
pair of small iAAA could bias this outcome, variation in 
the proportion of iAAA and rAAA repairs only in patients 
with ≥5.5-cm AAAs was also evaluated. This did not alter 
the wide variation seen between countries (rAAA as a 
proportion of all AAA repair ≥5.5 cm, 16%; range, 11% 
in United States–40% in Finland; P<0.01).
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discussiOn
This is the first analysis from a multinational collabora-
tion of vascular quality improvement organizations from 
sites in Australia, Europe, New Zealand, and the United 
States. This analysis demonstrated significant variation 
across countries in the rate of small iAAA treatment, the 
preferred surgical approach (EVAR versus open), the 
proportion of elderly patients undergoing repair, and the 
proportion of repairs performed for rupture. Variations 
existed both between countries and between centers 
within each country. The differences in indication for 
iAAA repair on the basis of the healthcare reimbursement 
model suggested differential management on the basis 
of positive or negative financial incentives. The analyses 
point toward the challenges in providing uniform health 
care to patients in different countries and centers de-
spite existing societal guidelines.
Both the SVS and ESVS recommend a size threshold 
of 5.5 cm for iAAA repair in men. The recommendation 
is less uniform in women with 5.0 cm by the SVS16 and 
5.2 cm by the ESVS.17 Despite this, there was significant 
variation both within and across Australia, Europe, New 
Zealand, and the United States in the proportion of iAAAs 
A
B
Figure 1. Variations in elective management of abdominal aortic aneurysm (aaa).  
A, Proportion of patients undergoing intact AAA repair at a diameter <5.5 cm for men (blue bars) and <5.0 cm in women (red 
bars) in each country. Both P<0.01 for difference between countries. B, Center-level analysis of proportion of patients under-
going intact AAA repair at an aneurysm diameter <5.5 cm for men and <5.0 cm in women. Each circle represents a center, 
and the size of the circle represents the volume of AAA repair at that center. Center-level data were not available for Germany, 
Norway, and New Zealand, which are represented by dotted circles.
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Country N paents
Hungary 849 27.8%(24.8%-30.8%)
Norway 2095 32.0%(30.0%-34.0%)
Denmark 2239 33.9%(31.9%-35.9%)
Finland 461 46.2%(41.7%-50.8%)
Switzerland 2174 50.3%(48.2%-52.4%)
New Zealand 1214 51.7%(48.9%-54.5%)
Iceland 76 53.9%(42.7%-65.2%)
Sweden 3893 56.8%(55.3%-58.4%)
Germany 12572 68.2%(67.4%-69.0%)
Australia 6306 73.7%(72.6%-74.8%)
United States 11819 79.4%(78.7%-80.2%)
Intact
% EVAR (95% CI)
20% 40% 60% 80% 100%
Country N paents
Denmark 748 5.1%(3.5%-6.7%)
Hungary 187 7.5%(3.7%-11.3%)
Finland 192 9.9%(5.7%-14.1%)
New Zealand 220 10.9%(6.8%-15.0%)
Norway 334 11.7%(8.2%-15.1%)
Iceland 21 19.0%(2.3%-35.8%)
Switzerland 342 24.9%(20.3%-29.4%)
Sweden 1038 29.3%(26.5%-32.1%)
Germany 1444 31.2%(28.8%-33.6%)
Australia 1444 39.8%(37.2%-42.3%)
United States 1075 51.8%(48.8%-54.8%)
Ruptured
% EVAR (95% CI)
0% 10% 20% 30% 40% 50% 60%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
A
B
C
Figure 2. Variations in modality of repair (open vs endovascular aortic repair [eVar]). 
Proportion of patients undergoing EVAR for intact (A) and ruptured (B) abdominal aortic aneurysm (AAA). C, Presentation of 
center-level variation within each country for the proportion of patients undergoing EVAR for intact AAA repair. Each circle repre-
sents a center, and the size of the circle represents the volume of AAA repair at that center. Center-level data were not available 
for Germany, Norway, and New Zealand, which are represented by dotted circles.
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being treated below the recommended diameter thresh-
old. The current SVS and ESVS guidelines are based in 
part on 2 randomized studies in the endovascular era, 1 
American study (PIVOTAL study [Positive Impact of En-
dovascular Options for Treating Aneurysms Early])7 and 
1 European study (CAESAR study [Comparison of Sur-
veillance Versus Aortic Endografting for Small Aneurysm 
Repair]),8 demonstrating that there is no survival benefit 
with repair of small AAA. This is due to the fact that rup-
ture risk of AAAs <5.5 cm in size is <1%/y on the basis 
of randomized trials.5–8 In a previous registry-based anal-
ysis, the perioperative mortality after intact AAA repair 
for aneurysms <5.5 cm was 0.7% for EVAR and 2.7% 
for open repair.20 These results were in line with the ran-
domized trials7,8 and indicate that repair of small AAA is 
unlikely to result in an overall survival benefit, even when 
performed with EVAR. With regard to open repair, 2 large, 
randomized trials did not show any benefit from repair of 
AAA <5.5 cm in size over 9 and 12 years of follow-up.5,6
The majority of repairs for small iAAA were in patients 
with a diameter within the 0.5-cm range below the treat-
ment threshold (5–5.4 cm in men and 4.5–4.9 mm in 
women), and small AAA repair was more prevalent with 
EVAR. The clinical rationale for repair at a small diameter 
is that more than half of the patients progress and meet 
the threshold for repair within 2 years of follow-up.8 How-
ever, the operative morbidity and mortality of iAAA repair 
cannot be neglected. It is important to note that patients 
with AAA have a lower life expectancy than age-matched 
cohorts because of disease in other vascular beds, ad-
vanced age, malignancy, and pulmonary disease,7,8 and 
repair of a small AAA with a low risk of rupture is un-
likely to improve the overall survival. Although we do not 
have complete data on the prior AAA expansion rate or 
symptomatic status as an indication for intact AAA repair, 
these effects should be similar across countries and are 
unlikely to explain the observed wide variation in practice.
The potential effects of different reimbursement mod-
els are provocative. The current data set does not al-
low differentiation of whether repair among patients with 
small AAA or the elderly was more prevalent in privately 
insured patients because of a lack of data on individual in-
surance status. However, data clearly indicate a tendency 
toward a lower threshold diameter for iAAA repair in fee-
Figure 3. aneurysm diameter related to 
endovascular aortic repair (eVar) and 
healthcare reimbursement model. 
Correlation of the proportion of small intact 
aneurysm repair per country and use of 
EVAR for intact abdominal aortic aneurysm 
repair. White dots represent countries with a 
population-based reimbursement system, and 
black dots represent countries with fee-for-
service reimbursement for surgical care. CI 
indicates confidence interval.
Figure 4. healthcare reimbursement 
related to management of small aneu-
rysms and elderly patients. 
Comparison of countries with a fee-for-service 
reimbursement system and those with a 
population-based reimbursement system in 
surgical care: proportions of patients with 
small aneurysm and proportions of octoge-
narians undergoing intact abdominal aortic 
aneurysm repair. Both P<0.01.
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for-service countries as a whole rather than in selected 
centers, suggesting financially biased patient selection.
In the last decade, EVAR has become the treatment of 
choice for patients with suitable aortic anatomy because 
of its less invasive nature and lower operative mortal-
ity.9–12 Anatomic eligibility varies for the currently available 
devices but is estimated to be 40% to 60% if the device 
instructions for use are followed.24 Small AAAs are known 
to be more often suitable for EVAR, which may explain the 
tendency for EVAR in countries with higher rates of small 
AAA repair.25 The use of EVAR for iAAA across countries 
varied significantly. The reasons for this variation are likely 
country, center, and surgeon specific. It is notable that the 
variation in operative technique was equally high between 
centers within each country. The center-level analysis in-
dicates that although EVAR is centralized to specific cen-
ters in some countries such as Denmark and Hungary, it 
is widely distributed in other countries, and the operative 
technique used for treatment of patients may be biased 
by the center where treatment is undertaken.
Data on variations in rAAA repair are especially inter-
esting, given the implications of repairing a small AAA 
versus one that has met a recommended size threshold. 
By definition, increasing numbers of small AAA repairs 
will increase the overall denominator and will decrease 
the apparent percentage of rAAA in any particular coun-
try. This does not necessarily indicate that these repairs 
prevented rupture, which is difficult to determine without 
a prospective study. Finland had the highest proportion of 
rAAA repairs in this cohort. According to a Finnish study, 
6.7% of the ruptures occurred in patients in whom the 
AAA diameter was below the ESVS recommendations for 
elective repair.26 Screening plays a large part in the detec-
tion of AAA in some but not most countries and may af-
fect the rate of repair of small AAA. Both the SVS and the 
ESVS recommend screening in men >65 years of age. 
Sweden is the only country in the present cohort with a 
broadly used national AAA screening program, although 
the US Medicare program offers an initial screening ab-
dominal ultrasound for selected patients. In addition, the 
rate of accidental detection of AAA may also vary be-
tween countries. The potential effect of these factors on 
AAA repair volume could not be assessed in this study. To 
assess whether the rate of small AAA repair is dependent 
on clinical decision making on the threshold for repair or 
is a potential effect of screening activity, the rate of small 
AAA was assessed focusing on the iAAA range of 4.5 to 
6 cm. This sensitivity analysis did not alter the variation 
seen between countries (data not shown).
limitations
Comorbidities are defined slightly differently in the vari-
ous registries, and center-specific information is lack-
ing in some countries as a result of pooling of data and 
patient data protection limitations. However, the inter-
national analyses of threshold for iAAA repair, operative 
technique, and age at repair are not affected by these 
parameters. The participating registries are validated lo-
cally, with several showing excellent internal and external 
validity for AAA data,27–30 but no validation of the ICVR 
data set as a whole was possible. Some of the partici-
pating registries are center or region based and do not 
cover all AAA repairs for a particular population base, 
which limits the possibility for detailed epidemiological 
assessment. ICVR is currently working to harmonize reg-
istry data points for future prospective studies, which 
will be guided by the results of this study. Although this 
study focused on patient treatment and presentation, ad-
ditional work is ongoing to determine individual center 
and country methodology for determining mortality and 
procedural outcomes to allow more detailed analyses. 
Despite these limitations, the current ICVR data set al-
lows an effective, broad analysis of the demonstration of 
international variation in AAA management.
conclusions
This study represents a unique international collabora-
tion providing data on the contemporary management 
of AAA in 11 countries across 3 continents. Despite 
existing recommendations from professional societies, 
remarkable differences exist across countries for diam-
eter threshold for iAAA repair, EVAR use, and the man-
agement of the elderly. Data suggest that healthcare 
system and reimbursement may have as much impact 
on treatment patterns and indication for surgery as sci-
entific studies and guidelines. This study demonstrates 
the opportunity for further international harmonization of 
treatment algorithms and additional assessment of the 
effects of variation on healthcare costs and outcome.
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SUPPLEMENTAL	MATERIALS	
Supplemental	Figure	1.	Case	selection	for	analysis.		
	
Supplemental	Table 1.	Number	of	procedures	per	year	in	each	registry.	
Intact	 Ruptured	
2010	 2011	 2012	 2013	 2010	 2011	 2012	 2013	
Australia	 1595	 1631	 1528	 1552	 363	 381	 375	 325	
Denmark	 532	 596	 573	 538	 212	 173	 152	 211	
Finland	 119	 117	 107	 118	 44	 48	 57	 43	
Germany	 4144	 3935	 3320	 1173	 520	 429	 382	 113	
Hungary	 221	 188	 194	 246	 54	 39	 53	 41	
Iceland	 11	 25	 26	 14	 11	 2	 4	 4	
Norway	 571	 496	 529	 499	 121	 89	 62	 62	
New	Zealand	 230	 306	 327	 351	 43	 54	 71	 52	
Sweden	 1017	 1023	 923	 930	 284	 246	 250	 258	
Switzerland	 521	 461	 558	 634	 109	 70	 86	 77	
USA	 955	 2128	 3802	 5325	 100	 193	 325	 476	
Supplemental		Table 2.	Risk	factor	definitions	within	countries.	
Country	 Diabetes	 Cardiac	history	 Pulmonary	disease	 Stroke	history	
Australia	 - Biochemically	proven,	treated	or
untreated		
- Previous	Angina,	MI,	CABG	or	PCI	
- ECG/Stress	test
Not	collected	 Not	collected	
Denmark	 - DM(I)
- DM(II)
- Angina
- Previous	myocardial	infarction
- Previous	CABG/PCI
- Treatment	for	lung	disease
- Severe	dyspnea
-	Previous	stroke	or	transient	ischemic	attack/
amaurosis	fugax	
Finland	 - DM(I)
- DM(II)
- Diet
- Previous	MI	or	CABG,	angina	pectoris,
congestive	heart	failure,	atrial	fibrillation	
- Diagnosis	of	chronic	obstructive
pulmonary	disease.	
- Previous	stroke	or	transient	ischemic	attack
Germany	 - DM(I)
- DM(II)
No	heart	disease	vs.	stable	vs.	instable	 -	Diagnosis	of	chronic	obstructive
pulmonary	disease.	
History	of	stroke	with	or	without	neurological	
deficite)	
Hungary	 - DM(I)
- DM(II)
- Previous	MI,	PCI	or	CABG,	angina	
pectoris,	congetstive	heart	failure	
- Diagnosis	of	chronic	obstructive
pulmonary	disease.	
Not	collected	
Iceland	 - DM(I)
- DM(II)
- Previous	MI,	PCI	or	CABG
- Angina
- Congestive	heart	failure
-	Diagnosis	of	chronic	obstructive
pulmonary	disease.	
- Previous	ischemic	stroke
- Previous	hemorrhagic	stroke
New	Zealand	 - Biochemically	proven,	treated	or
untreated	
- Previous	Angina,	MI,	CABG	or	PCI	
- ECG/Stress	test
Not	collected	 Not	collected	
Norway	 - DM(I)
- DM(II)
- Diet
- Ischemic	heart	disease
- Previous	MI	or	CABG
- Congestive	heart	failure
- Valvular	heart	disease
-	Diagnosis	of	chronic	obstructive
pulmonary	disease.	
- Previous	stroke	or	transient	ischemic	attack
Sweden	 - DM(I)
- DM(II)
- Previous	MI,	PCI	or	CABG
- Angina
- Congestive	heart	failure
- Diagnosis	of	chronic	obstructive
pulmonary	disease.	
- Previous	ischemic	stroke
- Previous	hemorrhagic	stroke
Switzerland	 - DM(I)
- DM(II)
- Angina
- Previous	myocardial	infarction
- CABG
- No	cardiac	decompensation
-	Diagnosis	of	chronic	obstructive
pulmonary	disease.	
Previous	stroke	
USA	–	Vascular	
Quality	Initiative	
- DM(I)
- DM(II)
- Diet
- Previous	MI,	PCI	or	CABG
- Angina
- Congestive	heart	failure
- Diagnosis	of	chronic	obstructive	
pulmonary	disease.	
Prior	CEA	or	CAS	collected	in	all	registries;	For	
Carotid	stent	and	endarterectomy,	detailed	
data	regarding	the	sidedness,	location	(eye,	
cortical,	vertebrobasilar)	and	severity	are	
collected,	including	a	pre-op	modified	Rankin	
Score	
DM(I):	Diabetes	mellitus	type	I,	DM(II):	Diabetes	mellitus	type	II,	MI:	Myocardial	infarction,	CABG:	Coronary	arterial	bypass	graft,		
Supplemental	Table 3.	Proportion	of	women	undergoing	intact	AAA	repair	at	a	diameter	<5.5cm	and	<5.2cm	in	different	registries.	
<5.5cm,	%	(95%	
CI)	
<5.2cm,	%	(95%	
CI)	
Australia	 38%	(35%-41%)	 26%	(23%-28%)	
Finland	 30%	(12%-47%)	 15%	(1%-28%)	
Germany	 39%	(34%-45%)	 25%	(20%-30%)	
Hungary	 33%	(24%-42%)	 23%	(15%-30%)	
Iceland	 15%	(0%-35%)	 0%	(0%-21%)	
Norway	 40%	(28%-40%)	 23%	(18%-27%)	
New	Zealand	 34%	(28%-40%)	 17%	(13%-23%)	
Sweden	 34%	(30%-38%)	 20%	(17%-23%)	
Switzerland	 41%	(29%-53%)	 23%	(13%-34%)	
USA	 49%	(47%-51%)	 30%	(29%-32%)	
